Mallat, Ariane

Publishing since 1990 (Dinosaur)

Has published 55 publications in 20 years

Number of publications published per year by Mallat, Ariane. (Source : PubMed)

Distribution of publications types for Mallat, Ariane. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Hezode C, Mallat A. [Comorbidity and hepatotoxicity of tobacco and recreational substances]  Gastroenterol. Clin. Biol.  2009;33;12  
•  Mallat A, Lotersztajn S. Cigarette smoke exposure: a novel cofactor of NAFLD progression?  J. Hepatol.  2009;51;3  
•  Mallat A, Lotersztajn S. [Liver fibrosis: from pathophysiology to therapeutic openings]  Gastroenterol. Clin. Biol.  2009;33;8-9  
•  Deveaux V, Cadoudal T, Ichigotani Y, Teixeira-Clerc F, Louvet A, Manin S, Nhieu JT, Belot MP, Zimmer A, Even P, Cani PD, Knauf C, Burcelin R, Bertola A, Le Marchand-Brustel Y, Gual P, Mallat A, Lotersztajn S. Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis.  PLoS ONE  2009;4;6  
•  Mallat A, Lotersztajn S. Cannabinoid receptors as novel therapeutic targets for the management of non-alcoholic steatohepatitis.  Diabetes Metab.  2008;34;6 Pt 2  
•  Luciani A, Vignaud A, Cavet M, Nhieu JT, Mallat A, Ruel L, Laurent A, Deux JF, Brugieres P, Rahmouni A. Liver cirrhosis: intravoxel incoherent motion MR imaging--pilot study.  Radiology  2008;249;3  
•  Mallat A, Lotersztajn S. Cannabinoid receptors as therapeutic targets in the management of liver diseases.  Drug News Perspect.  2008;21;7  
•  Mallat A, Hezode C, Lotersztajn S. Environmental factors as disease accelerators during chronic hepatitis C.  J. Hepatol.  2008;48;4  
•  Hézode C, Zafrani ES, Roudot-Thoraval F, Costentin C, Hessami A, Bouvier-Alias M, Medkour F, Pawlostky JM, Lotersztajn S, Mallat A. Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C.  Gastroenterology  2008;134;2  
•  Mallat A, Lotersztajn S. Endocannabinoids and liver disease. I. Endocannabinoids and their receptors in the liver.  Am. J. Physiol. Gastrointest. Liver Physiol.  2008;294;1  

[ See timeline ] [ See all publications ]